23andMe directors resign
23andMe independent board resigns in feud over CEO Anne Wojcicki’s plan to take company private
All seven of 23andMe’s independent board members resigned in a stinging rebuke to a proposal by CEO Anne Wojcicki’s plans to to take the company private. Wojcicki, who has been trying to take the company private since April, proposed to acquire all outstanding shares of 23andMe not owned by her or her affiliates for $0.40 per share, in July.
If you are a current holder of 23andMe Holding Co. stock, you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, ...
The pioneering DNA testing firm has been struggling to stay afloat financially despite ambitious ventures to provide health ...
On Tuesday, the independent directors of the Board of 23andMe Holding Co. (NASDAQ:ME) sent a letter to Anne Wojcicki, Chief ...
A 23andMe spokesperson offered no comment beyond the securities filings. Today 23andMe’s stock market value is less than $200 million, according to S&P Global Market Intelligence, just 3 percent ...
The biotech company 23andMe has a big mess to clean up after its entire board resigned to protest its CEO’s plans to take the ...
Shares for 23andMe have also plummeted — with the company's stock closing at 33 cents Thursday, down more than 97% since its 2021 stock market debut, according to FactSet. Wojcicki announced her ...
The board of Anne Wojcicki's genetic-testing company resigned earlier this week. This founder thinks he has a plan to save ...
Fox Business on MSN1d
Elizabeth O’Brien suggests potential path forward for ‘troubled’ 23andMeKamala Harris tells Oprah Winfrey that if someone breaks into her house ‘they’re getting shot’: ‘Probably shouldn’t have said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback